SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001729637-23-000006
Filing Date
2023-06-26
Accepted
2023-06-26 10:27:04
Documents
1
Period of Report
2023-04-25

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4/A  
1 PRIMARY DOCUMENT primary_doc.xml 4/A 4533
  Complete submission text file 0001729637-23-000006.txt   6151
Mailing Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2
Business Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2 1-800-936-9669
NYMOX PHARMACEUTICAL CORP (Issuer) CIK: 0001018735 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 10 EAST LEE STREET SUITE 2705 BALTIMORE MD 21202
Business Address
Robinson James George (Reporting) CIK: 0001651844 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-12033 | Film No.: 231040123